REGN

#200
Regeneron Pharmaceuticals Inc
752.07 USD
+0.75%
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
743.71
754.51
Rango anual
476.48
821.11
Cambio diario
+0.75%
Variación mensual
+0.28%
Variación en los últimos 6 meses
+30.79%
Cambio anual
+34.25%
Cierres anteriores
746.46
Abrir
744.88
Bid
Ask
Mínimo
743.71
High
754.51
Volumen
122
Ver el calendario completo

Financials

Visión general Informes Estadísticas Dividendos
Trimestre Año
  • Market Capitalization 79.51 B
  • Employee 15 K
  • Founded 1988
  • CEO Leonard Schleifer
  • Website www.regeneron.com
  • Headquarter New York, United States
  • FIGI BBG000C734W3
  • Industry Technology
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
18.61
Relación precio/flujo de caja
5.84

Regeneron Pharmaceuticals Inc

Regeneron Pharmaceuticals, Inc. is an American biotechnology company headquartered in Westchester County, New York. The company was founded in 1988. Originally focused on neurotrophic factors and their regenerative capabilities, giving rise to its present name; the company has since expanded operations into the study of both cytokine and tyrosine kinase receptors, which gave rise to their first product, which is a VEGF-trap.

Noticias